Antitumor_activities_of_interferon_alpha,_beta,_and_gamma_and_their_combinations_on_human_melanoma_cells_in_vitro:_changes_of_proliferation,_melanin_synthesis,_and_immunophenotype._The_antitumor_activities_of_human_interferon_(IFN)_alpha,_beta,_and_gamma_alone_or_in_combination_were_studied_on_four_human_melanoma_cell_lines_(StML-11,_StML-12,_StML-14,_and_SKMel-28)_in_various_concentrations_(1-50,000_IU/ml_IFN_alpha,_0.1-1000_IU/ml_IFN_beta,_1-10,000_IU/ml_IFN_gamma)_in_vitro._In_all_experiments_IFN_beta_exhibited_the_most_potent_antiproliferative_effect_of_all_IFN_tested._After_3_d_of_incubation_a_50%_growth_inhibition_was_achieved_with_20-40_IU/ml_for_natural_IFN_beta_and_with_600-1200_U/ml_for_recombinant_IFN_gamma._Substantially_higher_doses_(7,000_to_more_than_50,000_IU/ml)_of_recombinant_IFN_alpha_2a_were_required_to_achieve_a_50%_growth_inhibition._A_strong_synergistic_antiproliferative_activity_resulted_from_the_combination_of_IFN_alpha_with_IFN_gamma_and_IFN_beta_with_IFN_gamma._None_of_the_IFN_tested_induced_terminal_differentiation_of_melanoma_cells_in_vitro._The_formation_of_dendrites_was_inhibited,_and_the_portion_of_differentiated_cells_in_vitro_was_reduced_after_treatment_with_IFN_in_comparison_to_the_untreated_controls_(untreated_controls:_100%;_portion_of_differentiated_cells_after_treatment_with_IFN_alpha:_58%-74%,_IFN_beta:_48%-96%,_IFN_gamma:_10%-33%)._The_melanin_synthesis_was_slightly_elevated_after_treatment_with_IFN_alpha_(untreated_controls:_100%;_after_treatment_with_IFN_alpha:_103%-157%,_ns.)_and_decreased_significantly_after_treatment_with_IFN_beta_(49%-71%,_p_less_than_0.05)_as_well_as_with_IFN_gamma_(80%-88%,_ns.)._Cell_surface_markers_were_modulated_varyingly_by_the_IFN:_HLA-I_antigens_were_enhanced_by_all_IFN,_with_IFN_beta_emerging_as_the_most_potent_inducer._Only_IFN_gamma,_however,_induced_a_de_novo_expression_of_HLA-DR_and_-DQ_antigens_and_increased_the_expression_of_the_ICAM-1_molecule_and_of_the_melanoma_progression_marker_A.1.43._Possibly,_these_findings_indicate_a_biologically_more_aggressive_phenotype_of_melanoma_cells.